SCHEMBL6741682

SCHEMBL6741682

CCCCCCCCCC=CP(=O)(CP(=O)(OC)OC)OCC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPAR3 Q9UBY5 3/20 0.44
FAAH O00519 5/20 0.40
ALDH1A1 P00352 2/20 0.40
MEN1 O00255 1/20 0.40
MAPT P10636 1/20 0.40
PLA2G4A P47712 1/20 0.40
PAFAH1B2 P68402 1/20 0.40
KMT2A Q03164 1/20 0.40
MGLL Q99685 1/20 0.40
ABHD6 Q9BV23 1/20 0.40
LPAR1 Q92633 4/20 0.40
LPAR2 Q9HBW0 3/20 0.40
TRPV1 Q8NER1 1/20 0.37
S1PR4 O95977 2/20 0.35
S1PR1 P21453 2/20 0.35
S1PR3 Q99500 2/20 0.35
S1PR5 Q9H228 2/20 0.35
S1PR2 O95136 1/20 0.35
TSPO P30536 1/20 0.35
TMEM97 Q5BJF2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2959704 0.82 LPAR3 (0.51) LPAR3ALDH1A1LPAR1LPAR2S1PR4
SCHEMBL11279899 0.78 LPAR3 (0.49) LPAR3FAAHALDH1A1MEN1MAPT
SCHEMBL11279903 0.78 LPAR3 (0.49) LPAR3FAAHALDH1A1MEN1MAPT
SCHEMBL11268212 0.78 LPAR3 (0.49) LPAR3FAAHALDH1A1MEN1MAPT
SCHEMBL11268216 0.78 LPAR3 (0.49) LPAR3FAAHALDH1A1MEN1MAPT
SCHEMBL21638735 0.75 LPAR3 (0.53) LPAR3FAAHALDH1A1MEN1MAPT
SCHEMBL11273408 0.75 LPAR3 (0.53) LPAR3FAAHALDH1A1MEN1MAPT
SCHEMBL8052984 0.75 LPAR3 (0.53) LPAR3FAAHALDH1A1MEN1MAPT
SCHEMBL6542265 0.75 LPAR3 (0.53) LPAR3FAAHALDH1A1MEN1MAPT
SCHEMBL11447222 0.75 LPAR3 (0.53) LPAR3FAAHALDH1A1MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040019020-A1 Phosphate transport inhibitors GELTEX PHARMACEUTICALS, INC. 2004-01-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040019020-A1 Phosphate transport inhibitors SLC34A2, SLC43A1, SLC34A1 LPAR3 2860/4885FAAH 4045/4885ALDH1A1 1698/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.